ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,064 | -20.3% | 1,354,541 | -0.6% | 0.01% | 0.0% |
| Q2 2023 | $5,099 | +109.1% | 1,363,382 | +87.4% | 0.01% | +133.3% |
| Q1 2023 | $2,438 | -18.3% | 727,700 | +17.3% | 0.00% | -25.0% |
| Q4 2022 | $2,985 | -99.9% | 620,600 | +3.9% | 0.00% | -20.0% |
| Q3 2022 | $3,399,000 | -27.8% | 597,400 | -9.9% | 0.01% | -16.7% |
| Q2 2022 | $4,707,000 | -44.0% | 663,000 | -43.1% | 0.01% | -40.0% |
| Q1 2022 | $8,411,000 | +51.5% | 1,165,000 | +87.7% | 0.01% | +42.9% |
| Q4 2021 | $5,550,000 | +600.8% | 620,800 | +2646.9% | 0.01% | +600.0% |
| Q3 2021 | $792,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |